Susceptibility of various serogroups of streptococci to clindamycin and lincomycin.
作者信息
Karchmer A W, Moellering R C, Watson B K
出版信息
Antimicrob Agents Chemother. 1975 Feb;7(2):164-7. doi: 10.1128/AAC.7.2.164.
Abstract
The minimal inhibitory concentration of lincomycin and clindamycin for a large number of strains from multiple serogroups of streptococci was determined. The median minimal inhibitory concentration for streptococci from groups A, B, C, F, G, H, L, and M and nongroupable organisms ranged from 0.02 to 0.39 mug of lincomycin per ml and from </=0.01 to 0.09 mug of clindamycin per ml. Among the group D strains, Streptococcus faecium and Streptococcus faecalis were resistant to lincomycin and clindamycin, whereas Streptococcus bovis and four American strains of Streptococcus durans resembled nongroup D isolates in their susceptibility to these agents. Occasional strains of nongroup D streptococci were highly resistant to lincomycin and clindamycin.
摘要
相似文献
1
Susceptibility of various serogroups of streptococci to clindamycin and lincomycin.
Antimicrob Agents Chemother. 1975 Feb;7(2):164-7. doi: 10.1128/AAC.7.2.164.
2
Antibiotic susceptibilities of streptococci from the mouth and blood of patients treated with penicillin or lincomycin and clindamycin.
J Med Microbiol. 1976 Nov;9(4):393-404. doi: 10.1099/00222615-9-4-393.
3
[Frequency and in vitro antibiotic sensitivity of bacitracin-resistant beta-hemolytic streptococci from throat swab specimens].
Mikrobiyol Bul. 1989 Oct;23(4):312-7.
4
Effect of inoculum size on in vitro susceptibility testing with lincomycin.
Appl Microbiol. 1968 Nov;16(11):1663-8. doi: 10.1128/am.16.11.1663-1668.1968.
5
In-vitro comparison of erythromycin, lincomycin, and clindamycin.
Br Med J. 1970 Apr 11;2(5701):89-90. doi: 10.1136/bmj.2.5701.89.
6
Antimicrobial susceptibility of group B streptococci isolated from a variety of clinical sources.
Antimicrob Agents Chemother. 1976 Jul;10(1):128-31. doi: 10.1128/AAC.10.1.128.
7
Resistance to macrolide-lincosamide-streptogramin antibiotics in enterococci from the intestines of animals.
Res Vet Sci. 1982 Jul;33(1):70-2.
8
[Antibiotic sensitivity of streptococci of the A, B, C and G serogroups isolated in 1987-1990].
Antibiot Khimioter. 1993 Aug-Sep;38(8-9):30-3.
9
Can interchangeability of lincosamides be assumed in clinical practice? Comparative MICs of clindamycin and lincomycin for Streptococcus pyogenes, Streptococcus agalactiae and Staphylococcus aureus.
J Antimicrob Chemother. 2014 Mar;69(3):856-7. doi: 10.1093/jac/dkt436. Epub 2013 Oct 28.
10
[Antibacterial activity of clindamycin and lincomycin in broth, serum, and in combination with polymorphonuclear leukocytes against Staphylococcus aureus and Staphylococcus epidermidis].
Infection. 1984 Jul-Aug;12(4):280-5. doi: 10.1007/BF01645962.
引用本文的文献
1
Anti-anaerobic antimicrobial agents: cefoxitin, cefotetan, clindamycin, and metronidazole.
Tex Heart Inst J. 1990;17(2):77-85.
2
The life and times of the Enterococcus.
Clin Microbiol Rev. 1990 Jan;3(1):46-65. doi: 10.1128/CMR.3.1.46.
3
Antimicrobial susceptibility changes in Enterococcus faecalis following various penicillin exposure regimens.
Antimicrob Agents Chemother. 1992 Jan;36(1):121-5. doi: 10.1128/AAC.36.1.121.
4
Antimicrobial susceptibility of group B streptococci isolated from a variety of clinical sources.
Antimicrob Agents Chemother. 1976 Jul;10(1):128-31. doi: 10.1128/AAC.10.1.128.
5
Group B streptococci in human disease.
Bacteriol Rev. 1976 Sep;40(3):774-92. doi: 10.1128/br.40.3.774-792.1976.
本文引用的文献
1
Use of autoclaved extracts of hemolytic streptococci for serological grouping.
Stanford Med Bull. 1955 May;13(2):290-1.
2
MICROBIOLOGICAL, PHARMACOLOGICAL AND CLINICAL STUDIES OF LINCOMYCIN.
Am J Med Sci. 1965 Aug;250:137-46. doi: 10.1097/00000441-196508000-00003.
3
THE GROUP D STREPTOCOCCI.
Bacteriol Rev. 1964 Sep;28(3):330-66. doi: 10.1128/br.28.3.330-366.1964.
4
Susceptibility of group D streptococcus (enterococcus) to 21 antibiotics in vitro, with special reference to species differences.
Am J Med Sci. 1969 Dec;258(6):416-30. doi: 10.1097/00000441-196912000-00006.
5
Lincomycin: activity in vitro and absorption and excretion in normal young men.
Am J Med Sci. 1967 Aug;254(2):144-55.
6
Endocarditis due to group D streptococci. Comparison of disease caused by streptococcus bovis with that produced by the enterococci.
Am J Med. 1974 Aug;57(2):239-50. doi: 10.1016/0002-9343(74)90448-3.
7
Clindamycin: clinical and laboratory evaluation of parenteral therapy.
Am J Med Sci. 1972 May;263(5):368-82.
8
Resistance of group A beta-hemolytic streptococci to lincomycin and erythromycin.
Antimicrob Agents Chemother. 1972 Apr;1(4):333-9. doi: 10.1128/AAC.1.4.333.
9
Comparison of several laboratory media for presumptive identification of enterococci and group D streptococci.
Appl Microbiol. 1973 Aug;26(2):138-45. doi: 10.1128/am.26.2.138-145.1973.
10
Comparative studies of antibacterial activity in vitro and absorption and excretion of lincomycin and clinimycin.
Am J Med Sci. 1968 Nov;256(5):279-92. doi: 10.1097/00000441-196811000-00002.
Zotero 插件